ROSEN, A LEADING LAW FIRM, encourages Spectrum Pharmaceuticals to
NEW YORK, NY / ACCESSWIRE / January 23, 2023 / WHY: Rosen Law Firm, a global investor rights law firm, is reminding buyers of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) securities between December 6, 2021 and September 22, 2022, both dates inclusive (the “Collection Period”), that Important February 3, 2023 deadline for the plaintiff. SO WHAT: If […]
CENTESSA PHARMACEUTICALS SHAREHOLDER WARNING BY FORMER
NEW ORLEANS, Nov. 15, 2022 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Louisiana Attorney General Charles C. Foti, Jr., remind investors that they still have time November 28, 2022 Lead Plaintiff motions to file in a securities class action against Centessa Pharmaceuticals plc (NasdaqGS: CNTA) if they purchased or […]
SHAREHOLDER OF CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA).
Have you lost money investing in Centessa Pharmaceuticals? If yes, please visit us Class Action by Centessa Pharmaceuticals plc Shareholders or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights. NEW YORK, Nov. 15, 2022 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP, a nationally recognized investor rights law firm, is reminding investors of […]
EIGER BIOPHARMACEUTICALS, INC. (NASDAQ: EIGR) SHAREHOLDER
Have you lost money investing in Eiger BioPharmaceuticals, Inc.? If yes, please visit us Eiger BioPharmaceuticals, Inc. Shareholder Class Action or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights. NEW YORK, Nov. 15, 2022 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP, a nationally recognized investor rights law firm, is reminding investors of […]
Eiger Biopharmaceuticals, Inc. (EIGR) Shareholder Warning:
SAN DIEGO, Nov. 11, 2022 (GLOBE NEWSWIRE) — The class: Robbins LLP Reminds investors that a shareholder is bringing a class action lawsuit alleging violations of filed the Securities Exchange Act of 1934. Eiger is a commercial-stage biopharmaceutical company focused on the development and commercialization of targeted therapies for rare and ultra-rare diseases. What now: […]
ROSEN, A LEADING LAW FIRM, empowers Eiger BioPharmaceuticals,
NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces that it will file a class action lawsuit on behalf of purchasers of Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) securities between March 10, 2021 and October 4, 2022, both dates inclusive (the “Class Period”). A class action […]
FILING DEADLINE – Kuznicki Law PLLC announces class action lawsuit
CEDARHURST, NY, Nov. 09, 2022 (GLOBE NEWSWIRE) — The securities litigation practice of Kuznicki Law PLLC is issuing this warning to shareholders of Centessa Pharmaceuticals plc (NasdaqGS: CNTA) if they purchased the company’s securities between May and otherwise acquired June 28, 2021 and June 1, 2022 inclusive (the “Collection Period”) and/or the Company’s American Depositary […]
Gainey McKenna & Egleston announces a class action lawsuit
NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) — Gainey McKenna & Egleston announce that it has filed a securities class action in the United States District Court for the Northern District of California on behalf of all individuals or entities that purchased Eiger became BioPharmaceuticals (“Eiger” or “Company”) (NYSE: EIGR) between March 10, 2021 and […]
EIGER BIOPHARMACEUTICALS, INC. (NASDAQ: EIGR) SHAREHOLDER
Have you lost money investing in Eiger BioPharmaceuticals, Inc.? If yes, please visit us Eiger BioPharmaceuticals, Inc. Shareholder Class Action or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights. NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP announces that on behalf of investors holding the securities of Eiger […]
ALERT TO OLO PHARMACEUTICALS SHAREHOLDERS: DAMAGES REMINDER
NEW ORLEANS, Nov. 08, 2022 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, is reminding investors that they have until November 28, 2022 Lead plaintiff motions in a securities class action lawsuit against Olo Inc. (NYSE: OLO) if they purchased the Company’s stock between August 11, 2021 and August 11, 2022 inclusive (the “Class […]
CENTESSA PHARMACEUTICALS SHAREHOLDER WARNING: APPLICANTS
NEW ORLEANS, Nov. 08, 2022 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, is reminding investors that they have until November 28, 2022 Lead Plaintiff motions to file in a securities class action lawsuit against Centessa Pharmaceuticals plc (NasdaqGS: CNTA) if they purchased or otherwise acquired the Company’s securities between May 28, 2021 and […]
Class action lawsuit brought by Eiger BioPharmaceuticals: Johnson fistula
SAN DIEGO, Nov. 08, 2022 (GLOBE NEWSWIRE) — The shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistula.com) examines whether Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), one of its officers or others has violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors’ losses and whether they […]